AAAAAA

   
Results: 1-25 | 26-47
Results: 1-25/47

Authors: Borderi, M Verucchi, G Tadolini, M Spinosa, S Fortunato, L Talo, S Chiodo, F
Citation: M. Borderi et al., Metabolic complications of HIV-1 antiretroviral therapy: The lipodystrophysyndrome, MICROBIOLO, 24(3), 2001, pp. 303-315

Authors: Calza, L Manfredi, R Marinacci, G Briganti, E Giuliani, R Talo', S Chiodo, F
Citation: L. Calza et al., Role of gancyclovir and HAART administration in the treatment of a rare complication of HIV disease: Cytomegalovirus-associated Guillain-Barre syndrome, J CHEMOTHER, 13(5), 2001, pp. 575-577

Authors: Manfredi, R Nanetti, A Ferri, M Chiodo, F
Citation: R. Manfredi et al., Enterobacter spp. infections complicating the course of HIV disease, J CHEMOTHER, 13(2), 2001, pp. 195-201

Authors: Calza, L Manfredi, R Mastroianni, A Chiodo, F
Citation: L. Calza et al., Osteonecrosis and highly active antiretroviral therapy during HIV infection: Report of a series and literature review, AIDS PAT CA, 15(7), 2001, pp. 385-389

Authors: Manfredi, R Calza, L Chiodo, F
Citation: R. Manfredi et al., Gynecomastia associated with highly active antiretroviral therapy, ANN PHARMAC, 35(4), 2001, pp. 438-439

Authors: Manfredi, R Chiodo, F
Citation: R. Manfredi et F. Chiodo, Switch of protease inhibitor-containing HAART in routine clinical practice: a four-year prospective observational study, INT J STD A, 12(2), 2001, pp. 84-88

Authors: Manfredi, R Calza, L Chiodo, F
Citation: R. Manfredi et al., Lack of change in the distribution of AIDS-defining opportunistic diseasesand the related degree of immunodeficiency during the periods before and after the introduction of highly active antiretroviral therapy, EUR J CL M, 20(6), 2001, pp. 410-413

Authors: Manfredi, R Chiodo, F
Citation: R. Manfredi et F. Chiodo, Limits of deep salvage antiretroviral therapy with nelfinavir plus either efavirenz or nevirapine, in highly pre-treated patients with HIV disease, INT J ANT A, 17(6), 2001, pp. 511-516

Authors: Calza, L Manfredi, R Chiodo, F
Citation: L. Calza et al., Burkitt's lymphoma characterized by an atypic lesion in an HIV-infected patient, PRESSE MED, 30(31), 2001, pp. 1552-1553

Authors: Calza, L Manfredi, R Chiodo, F
Citation: L. Calza et al., Parvovirus B19 glove and socks papulopurpura in an adult woman, PRESSE MED, 30(27), 2001, pp. 1354-1354

Authors: Manfredi, R Calza, L Chiodo, F
Citation: R. Manfredi et al., Dual nucleoside analogue treatment in the era of highly active antiretroviral therapy (HAART): a single-centre cross-sectional survey, J ANTIMICRO, 48(2), 2001, pp. 299-302

Authors: Manfredi, R Calza, L Chiodo, F
Citation: R. Manfredi et al., Carpal tunnel syndrome in HIV-infected patients treated with highly activeantiretroviral therapy: other case reports, RHEUM INTL, 21(2), 2001, pp. 81-83

Authors: Manfredi, R Chiodo, F
Citation: R. Manfredi et F. Chiodo, Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: Frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate, J INFECTION, 42(3), 2001, pp. 181-188

Authors: Calza, L Manfredi, R Briganti, E Attard, L Chiodo, F
Citation: L. Calza et al., Iliac osteomyelitis and gluteal muscle abscess caused by Streptococcus intermedius, J MED MICRO, 50(5), 2001, pp. 480-482

Authors: Manfredi, R Nanetti, A Valentini, R Chiodo, F
Citation: R. Manfredi et al., Acinetobacter infections in patients with human immunodeficiency virus infection: Microbiological and clinical epidemiology, CHEMOTHERA, 47(1), 2001, pp. 19-28

Authors: Manfredi, R Chiodo, F
Citation: R. Manfredi et F. Chiodo, Switch to an antiretroviral treatment of expected lower potency after effective highly active antiretroviral therapy (HAART), J ACQ IMM D, 23(1), 2000, pp. 95-98

Authors: Manfredi, R Chiodo, F
Citation: R. Manfredi et F. Chiodo, Features of AIDS and AIDS defining diseases during the highly active antiretroviral therapy (HAART) era, compared with the pre-HAART period: a case-control study, SEX TRANS I, 76(2), 2000, pp. 145-146

Authors: Manfredi, R Nanetti, A Valentini, R Chiodo, F
Citation: R. Manfredi et al., Moraxella catarrhalis pneumonia during HIV disease, J CHEMOTHER, 12(5), 2000, pp. 406-411

Authors: Manfredi, R Nanetti, A Ferri, M Chiodo, F
Citation: R. Manfredi et al., Pseudomonas organisms other than Pseudomonas aeruginosa as emerging bacterial pathogens in patients with human immunodeficiency virus infection, INF DIS C P, 9(2), 2000, pp. 79-87

Authors: Manfredi, R Alampi, G Talo, S Calza, L Tadolini, M Martinelli, GN Chiodo, F
Citation: R. Manfredi et al., Silent oophoritis due to cytomegalovirus in a patient with advanced HIV disease, INT J STD A, 11(6), 2000, pp. 410-412

Authors: Manfredi, R Chiodo, F
Citation: R. Manfredi et F. Chiodo, Four-drug salvage antiretroviral treatment including nelfinavir and efavirenz in highly treated children with congenital HIV disease, INT J STD A, 11(2), 2000, pp. 132-133

Authors: Manfredi, R Nanetti, A Ferri, M Chiodo, F
Citation: R. Manfredi et al., Clinical and microbiological survey of Serratia marcescens infection during HIV disease, EUR J CL M, 19(4), 2000, pp. 248-253

Authors: Manfredi, R Chiodo, F
Citation: R. Manfredi et F. Chiodo, The effects of alternative treatments for HIV disease on recommended pharmacological regimens, INT J ANT A, 13(4), 2000, pp. 281-285

Authors: Varani, S Spezzacatena, P Manfredi, R Chiodo, F Mastroianni, A Ballarini, P Boschini, A Lazzarotto, T Landini, MP
Citation: S. Varani et al., The incidence of cytomegalovirus (CMV) antigenemia and CMV disease is reduced by highly active antiretroviral therapy, EUR J EPID, 16(5), 2000, pp. 433-437

Authors: Manfredi, R Nanetti, A Ferri, M Chiodo, F
Citation: R. Manfredi et al., Pseudomonas spp. complications in patients with HIV disease: An eight-yearclinical and microbiological survey, EUR J EPID, 16(2), 2000, pp. 111-118
Risultati: 1-25 | 26-47